148 results in Exploration of Drug Science
Most Downloaded
Sort by :
- Latest
- Most Viewed
- Most Downloaded
- Most Cited
Open Access
Original Article
Mechanism of the blood-brain barrier modulation by cadherin peptides
Elinaz Farokhi ... Teruna J. Siahaan
Published: June 26, 2024 Explor Drug Sci. 2024;2:322–338
Open Access
Original Article
Binding copper(II) ion released from azo-amino acid Schiff base complex into lysozyme crystals as models for treatment of Alzheimer’s disease
Ayumu Odaka ... Takashiro Akitsu
Published: December 15, 2025 Explor Drug Sci. 2025;3:1008137
Open Access
Original Article
A dextrorotatory residues-incorporated bioactive dodecapeptide against enterohemorrhagic Escherichia coli
Ping Zeng ... Lanhua Yi
Published: June 30, 2023 Explor Drug Sci. 2023;1:210–220
This article belongs to the special issue Bioactive Peptides discovery and development
Open Access
Systematic Review
Targeted therapeutic management of diabetes using phytoconstituents: molecular mechanisms, evidence map (2015–2025), and translational outlook
Chizurum Philip Ikegbuna ... Mmesoma Ruth Ikegbuna
Published: January 07, 2026 Explor Drug Sci. 2026;4:1008139
Open Access
Case Report
Reactivation of latent hepatitis B infection during immunosuppressive therapy with guselkumab for plaque psoriasis: a case report
Elena Franchi ... Pietro Andreone
Published: December 27, 2023 Explor Drug Sci. 2023;1:468–474
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Original Article
Insights into the binding selectivity of harzianoic acids A and B to tetraspanin CD81
Gérard Vergoten, Christian Bailly
Published: November 01, 2023 Explor Drug Sci. 2023;1:405–419
Open Access
Letter to the Editor
Further considerations to improve the druggability of biaryl hydroxy-triazole and fluorene-triazole hybrids
Zhiqi Liu ... Zhengwei Huang
Published: November 20, 2025 Explor Drug Sci. 2025;3:1008134
Open Access
Original Article
Interaction of norsecurinine-type monomeric and dimeric alkaloids with α-tubulin: a molecular docking study
Gérard Vergoten, Christian Bailly
Published: May 21, 2024 Explor Drug Sci. 2024;2:277–291
Open Access
Commentary
Could flavonoid aglycones prevent the absorption of flavonoid glycosides by inhibiting sodium-dependent glucose transporter-1 in the small intestine?
Katrin Sak
Published: August 30, 2023 Explor Drug Sci. 2023;1:287–291
Open Access
Review
Innovative immunotherapies for prostate cancer: understanding the synergies between checkpoint inhibition, CAR T-cell therapy, and next-generation therapeutic modalities
Daniel Kofi Nyame ... Xiaohui Zhou
Published: January 09, 2026 Explor Drug Sci. 2026;4:1008141
Open Access
Case Report
Single or multiple treatments with lusutrombopag in subjects with thrombocytopenia and chronic liver disease needing an invasive procedure
Davide Scalabrini ... Pietro Andreone
Published: August 30, 2023 Explor Drug Sci. 2023;1:292–298
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Systematic Review
Janus-faced role of anti-infective drugs: a revisit through the lens of vascular ageing
Ceaser Wankumbu Silumbwe ... Kebby Mazyamuna
Published: January 14, 2026 Explor Drug Sci. 2026;4:1008143
Open Access
Original Article
Rational design of novel phenol ether derivatives as non-covalent proteasome inhibitors through 3D-QSAR, molecular docking and ADMET prediction
Miao Yuan ... Ping Cheng
Published: December 27, 2023 Explor Drug Sci. 2023;1:435–453
This article belongs to the special issue Machine Learning for Drug Science
Open Access
Case Report
Histological diagnosis of primary biliary cholangitis in one patient without cholestasis alterations: a case report that escaped guidelines
Matteo Biagi ... Pietro Andreone
Published: January 22, 2024 Explor Drug Sci. 2024;2:1–5
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Correction
Correction: Folic acid conjugated with serum albumin for nano- and submicron delivery systems for applications in therapy and diagnostics
Maria G. Gorobets ... Anna V. Bychkova
Published: September 24, 2025 Explor Drug Sci. 2025;3:1008130
Open Access
Original Article
Novel antimicrobial efficacy on inert surfaces of chlorhexidine-silver nanoparticle veterinary formulation
Daniel Buldain ... Laura Marchetti
Published: January 05, 2026 Explor Drug Sci. 2026;4:1008138
This article belongs to the special issue Discovery and development of new antibacterial compounds
Open Access
Review
Iron depletion in “metabolic fatty liver syndromes”: a strong biological rationale with disappointing liver outcomes
Amedeo Lonardo
Published: August 28, 2023 Explor Drug Sci. 2023;1:239–252
Open Access
Original Article
Clinical utility of combined contrast-enhanced ultrasound and intracavitary contrast-enhanced ultrasound in the percutaneous treatment of pyogenic liver abscess
Giampiero Francica
Published: September 13, 2024 Explor Drug Sci. 2024;2:555–566
This article belongs to the special issue Innovative Therapeutics in Hepato-Gastroenterology
Open Access
Retraction
Retraction: Controlled release of dexamethasone phosphate from modified mesoporous biocompatible silica nanoparticles: synthesis, characterization, and kinetic studies
Juan Manuel Galdopórpora ... María Victoria Tuttolomondo
Published: March 17, 2025 Explor Drug Sci. 2025;3:100896
Open Access
Systematic Review
Harnessing nanomaterials to overcome antimicrobial resistance in Gram-positive bacteria: a systematic review
Olalekan John Okesanya ... Don Eliseo Lucero-Prisno III
Published: January 28, 2026 Explor Drug Sci. 2026;4:1008144
PreviousJournal Information